首页> 外文期刊>Pediatric emergency care >Hyaluronidase-Assisted Resuscitation in Kenya for Severely Dehydrated Children
【24h】

Hyaluronidase-Assisted Resuscitation in Kenya for Severely Dehydrated Children

机译:透明质酸酶辅助复苏在肯尼亚严重脱水儿童

获取原文
获取原文并翻译 | 示例
           

摘要

Background Dehydration, mainly due to diarrheal illnesses, is a leading cause of childhood mortality worldwide. Intravenous (IV) therapy is the standard of care for patients who were unable to tolerate oral rehydration; however, placing IVs in fragile, dehydrated veins can be challenging. Studies in resource-rich settings comparing hyaluronidase-assisted subcutaneous rehydration with standard IV rehydration in children have demonstrated several benefits of subcutaneous rehydration, including time and success of line placement, ease of use, satisfaction, and cost-effectiveness. Methods A single-arm trial assessing the feasibility of hyaluronidase-assisted subcutaneous resuscitation for the treatment of moderately to severely dehydrated individuals in western Kenya was conducted. Children aged 2 months or older who presented with moderately to severely dehydration clinically warranting parenteral rehydration and had at least 2 failed IV attempts were eligible. Study staff received training on standard dehydration management and hyaluronidase infusion processes. Children received all other standards of care. They were monitored from presentation and through discharge, with a 1-week phone follow-up. Predischarge surveys were completed by caregivers, and semistructured interviews with providers were performed. Results A total of 51 children were enrolled (median age, 13.0 months; interquartile range of 18 months). Fifty-one patients (100%) had severe dehydration. The median length of subcutaneous infusion was 3.0 hours (interquartile range [IQR], 2.95). The median total subcutaneous infusion was 700.0 mL (IQR, 420 mL). Median time to resolution of moderate to severe dehydration symptoms was 3.0 hours (IQR, 2.95 hours). There were no significant complications. Conclusions Hyaluronidase-assisted subcutaneous resuscitation is a feasible alternative to IV hydration in moderately to severely dehydrated children with difficult to obtain IV access in resource-limited areas.
机译:背景脱水主要是由于腹泻疾病,是全世界儿童死亡率的主要原因。静脉注射(IV)治疗是无法忍受口腔复合的患者的护理标准;然而,将IVS放入易碎的脱水静脉可能是挑战性的。富含资源富含水合物的富含资源的环境的研究与儿童标准IV补液进行了疗效,展示了皮下再水水的几个好处,包括线放置的时间和成功,易用,满意度和成本效益。方法采用单臂试验评估透明质酸酶辅助皮下复苏的可行性,用于治疗适度施用于肯尼亚西部的严重脱水个体。 2个月或更年长的儿童适度地呈现,以严重脱水临床保证肠胃外再水解,并且至少有2次失败的IV次尝试符合条件。研究人员接受了对标准脱水管理和透明质酸酶输注过程的培训。孩子们获得了所有其他其他护理标准。他们由演示和通过放电监控,一个周的手机随访。通过护理人员完成了Predisharge调查,并进行了与提供商的半结构面试。结果共有51名儿童(中位年龄,13.0个月; 18个月的四分位数)。五十一名患者(100%)具有严重的脱水。皮下注射的中值长度为3.0小时(间环范围[IQR],2.95)。中值皮下注射为700.0ml(IQR,420mL)。中位时间为中度至重度脱水症状的时间为3.0小时(IQR,2.95小时)。没有显着的并发症。结论透明质酸酶辅助皮下复苏是对IV水化的可行替代方案,其适度至严重脱水的儿童,难以在资源有限的区域中获得IV接近。

著录项

  • 来源
    《Pediatric emergency care》 |2019年第10期|共4页
  • 作者单位

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

    Sagam Community Hosp African Inst Hlth Transformat Sagam Kenya;

    Massachusetts Gen Hosp Dept Emergency Med Div Global Hlth &

    Human Rights 125 Nashua St Suite 910;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 儿科学;
  • 关键词

    hyaluronidase; subcutaneous infusion; dehydration; diarrheal illness; intravenous line;

    机译:透明酶;皮下注射;脱水;腹泻病;静脉注射;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号